These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

893 related items for PubMed ID: 18226766

  • 1. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL, Marshall J, Bock J, Dowling TC, Feller E, Robinson S, Gottlieb SS.
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [Abstract] [Full Text] [Related]

  • 2. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.
    Costanzo MR, Saltzberg MT, Jessup M, Teerlink JR, Sobotka PA, Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure (UNLOAD) Investigators.
    J Card Fail; 2010 Apr; 16(4):277-84. PubMed ID: 20350693
    [Abstract] [Full Text] [Related]

  • 3. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S, Warfield KT, Wood CM, Miller WL.
    Am J Cardiol; 2006 Dec 15; 98(12):1627-30. PubMed ID: 17145223
    [Abstract] [Full Text] [Related]

  • 4. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
    Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB.
    J Card Fail; 2010 Mar 15; 16(3):188-93. PubMed ID: 20206891
    [Abstract] [Full Text] [Related]

  • 5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 15; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 6. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
    De Maria E, Pignatti F, Patrizi G, Benenati PM, Ricci S, Cappelli S.
    J Cardiovasc Med (Hagerstown); 2010 Aug 15; 11(8):599-604. PubMed ID: 20442667
    [Abstract] [Full Text] [Related]

  • 7. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov 15; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 8. Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center.
    Liang KV, Hiniker AR, Williams AW, Karon BL, Greene EL, Redfield MM.
    J Card Fail; 2006 Dec 15; 12(9):707-14. PubMed ID: 17174232
    [Abstract] [Full Text] [Related]

  • 9. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC, CKI-201 and CKI-202 Investigators.
    J Am Coll Cardiol; 2007 Oct 16; 50(16):1551-60. PubMed ID: 17936154
    [Abstract] [Full Text] [Related]

  • 10. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
    Giamouzis G, Butler J, Starling RC, Karayannis G, Nastas J, Parisis C, Rovithis D, Economou D, Savvatis K, Kirlidis T, Tsaknakis T, Skoularigis J, Westermann D, Tschöpe C, Triposkiadis F.
    J Card Fail; 2010 Dec 16; 16(12):922-30. PubMed ID: 21111980
    [Abstract] [Full Text] [Related]

  • 11. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial.
    Bart BA, Boyle A, Bank AJ, Anand I, Olivari MT, Kraemer M, Mackedanz S, Sobotka PA, Schollmeyer M, Goldsmith SR.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):2043-6. PubMed ID: 16325039
    [Abstract] [Full Text] [Related]

  • 12. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S, Parrinello G, Cannizzaro S, Fasullo S, Torres D, Sarullo FM, Di Pasquale P.
    Am J Cardiol; 2009 Jan 01; 103(1):93-102. PubMed ID: 19101237
    [Abstract] [Full Text] [Related]

  • 13. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial.
    Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D.
    Eur J Cardiothorac Surg; 2008 Mar 01; 33(3):370-6. PubMed ID: 18243724
    [Abstract] [Full Text] [Related]

  • 14. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
    Udelson JE, Orlandi C, Ouyang J, Krasa H, Zimmer CA, Frivold G, Haught WH, Meymandi S, Macarie C, Raef D, Wedge P, Konstam MA, Gheorghiade M.
    J Am Coll Cardiol; 2008 Nov 04; 52(19):1540-5. PubMed ID: 19007589
    [Abstract] [Full Text] [Related]

  • 15. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R, Ciccarelli A, Ariano C, Cioppa C, Giasi A, Pucciarelli A, Cantatrione S.
    Minerva Cardioangiol; 2011 Dec 04; 59(6):543-54. PubMed ID: 21330961
    [Abstract] [Full Text] [Related]

  • 16. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC, Gupta DK, Hack TC, Dowling T, Callahan J, Thomson S.
    J Card Fail; 2007 Oct 04; 13(8):609-17. PubMed ID: 17923351
    [Abstract] [Full Text] [Related]

  • 17. Ultrafiltration in the management of heart failure.
    Costanzo MR.
    Curr Opin Crit Care; 2008 Oct 04; 14(5):524-30. PubMed ID: 18787444
    [Abstract] [Full Text] [Related]

  • 18. Fluid removal: are we any wiser?
    Ghali JK, Vaitkevicius P.
    J Card Fail; 2008 Feb 04; 14(1):6-8. PubMed ID: 18226767
    [No Abstract] [Full Text] [Related]

  • 19. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A.
    Clin Pharmacol Ther; 1997 Aug 04; 62(2):187-93. PubMed ID: 9284855
    [Abstract] [Full Text] [Related]

  • 20. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
    van der Voort PH, Boerma EC, Koopmans M, Zandberg M, de Ruiter J, Gerritsen RT, Egbers PH, Kingma WP, Kuiper MA.
    Crit Care Med; 2009 Feb 04; 37(2):533-8. PubMed ID: 19114909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.